Abstract:Background Anaphylaxis is a potentially fatal condition; in severe cases of anaphylaxis, the cardiovascular system is often heavily involved. Adrenaline (epinephrine) is a cornerstone of the initial treatment of anaphylaxis. The use of epinephrine remains below expectations in clinical practice. Whether the underuse of epinephrine affects the prognosis of patients with anaphylaxis is still unclear. Materials and methods This retrospective study included patients with anaphylaxis between 2011 and 2020 who were admitted to an emergency department (ED) in Taiwan. All patients were divided into two groups based on the use of epinephrine (or not), and we compared the demographic characteristics, allergens, clinical manifestations, management, and patient outcomes. Results We reviewed the records of 314 subjects (216 males, 98 females; mean age: 52.78 ± 16.02 years) who visited our ED due to anaphylaxis; 107 (34.1%) and 207 (65.9%) patients were categorized into the epinephrine use group and the non-epinephrine use group, respectively. Arrival via ambulance ( p = 0.019), hypotension ( p = 0.002), airway compromise ( p < 0.001) and altered consciousness ( p < 0.001) were the deciding factors for epinephrine use among anaphylactic patients in the ED. The epinephrine use group had higher rates of other inotropic agent usage and fluid challenge. More than 90% of patients received bed rest, steroids, antihistamines, and monitoring. The epinephrine use group had a longer ED length of stay (387.64 ± 374.71 vs. 313.06 ± 238.99 min, p = 0.03) and a greater need of hospitalization. Among all severe symptoms, hypotension was the most tolerated decision factor for not using epinephrine. In this retrospective analysis, some patients with serious anaphylaxis did not experience adverse outcomes or death even without the use of epinephrine at ED admission. Emergent care focuses first on the airway, breathing, and circulation (ABC) and may compensate for the underusage of epinephrine. This could be the reason why epinephrine was underused among patients with anaphylaxis in the ED. Conclusion In summary, early ABC management continues to play an important role in treating patients with severe anaphylaxis, even when epinephrine is not immediately available in clinical scenarios.

[Sideroelastosis of pulmonary vessels after welder dust exposure].

Intranasal epinephrine in dogs: Pharmacokinetic and heart rate effects

The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease.

Randomized Trial of Pharmacokinetic and Pharmacodynamic Effects of 13.2 mg Intranasal Epinephrine Treatment in Congestion

Population pharmacokinetic and pharmacodynamic modeling of epinephrine administered using a mobile inhaler

Epinephrine in Anaphylaxis: Preclinical Study of Pharmacokinetics after Sublingual Administration of Taste-Masked Tablets for Potential Pediatric Use

A Health Economic Analysis of Non-injectable Epinephrine Compared with Intramuscular Epinephrine

Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.

Addressing Multiplicity Issues of a Composite Endpoint and Its Components in Clinical Trials

Use of Epinephrine in Patients with Drug-Induced Anaphylaxis: an Analysis of the Beijing Pharmacovigilance Database

Nose-to-Heart Approach: Unveiling an Alternative Route of Acute Treatment

Computational similarity

The use of intranasal analgesia for acute pain control in the emergency department: A literature review

Outcomes Associated with Prehospital Epinephrine in Adult and Pediatric Anaphylaxis Patients

Investigation of the underuse of adrenaline (epinephrine) and prognosis among patients with anaphylaxis at emergency department admission

Development of neffy, an Epinephrine Nasal Spray, for Severe Allergic Reactions

Blood Pressure Reduction Induced By Low Dose Of Epinephrine Via Different Routes In Rats

Pharmacokinetic and pharmacodynamic evidence of adrenaline administered via auto-injector for anaphylactic reactions: A review of literature

In Vivo Evaluation of Taste-Masked Fast-Disintegrating Sublingual Tablets of Epinephrine Microcrystals

Bioavailability and Stability of an Epinephrine Nasal Powder Formulation for Treatment of Anaphylaxis

Effect of epinephrine on the absorption of lidocaine following application to the oral mucosa in rats